pH-Dependent Cellular Internalization of Paramagnetic Nanoparticle
- PMID: 28066811
- PMCID: PMC5214587
- DOI: 10.1021/acssensors.6b00396
pH-Dependent Cellular Internalization of Paramagnetic Nanoparticle
Abstract
A hallmark of the tumor microenvironment in malignant tumor is extracellular acidosis, which can be exploited for targeted delivery of drugs and imaging agents. A pH sensitive paramagnetic nanoaparticle (NP) is developed by incorporating GdDOTA-4AmP MRI contrast agent and pHLIP (pH Low Insertion Peptide) into the surface of a G5-PAMAM dendrimer. pHLIP showed pH-selective insertion and folding into cell membranes, but only in acidic conditions. We demonstrated that pHLIP-conjugated Gd44-G5 paramagnetic nanoparticle binds and fuses with cellular membrane at low pH, but not at normal physiological pH, and that it promotes cellular uptake. Intracellular trafficking of NPs showed endosomal/lysosomal path ways.
Keywords: Cell internalization; MRI; intracellular trafficking; pH sensing probe; paramagnetic nanoparticle.
Figures




Similar articles
-
Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy.Transl Oncol. 2020 Nov;13(11):100839. doi: 10.1016/j.tranon.2020.100839. Epub 2020 Aug 4. Transl Oncol. 2020. PMID: 32763504 Free PMC article.
-
Concentration-independent MRI of pH with a dendrimer-based pH-responsive nanoprobe.Contrast Media Mol Imaging. 2015 Nov-Dec;10(6):481-6. doi: 10.1002/cmmi.1651. Epub 2015 Jul 14. Contrast Media Mol Imaging. 2015. PMID: 26173742 Free PMC article.
-
A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.Drug Deliv. 2016 Jun;23(5):1734-46. doi: 10.3109/10717544.2015.1028601. Epub 2015 Apr 8. Drug Deliv. 2016. PMID: 25853477
-
Targeting diseased tissues by pHLIP insertion at low cell surface pH.Front Physiol. 2014 Mar 13;5:97. doi: 10.3389/fphys.2014.00097. eCollection 2014. Front Physiol. 2014. PMID: 24659971 Free PMC article. Review.
-
Applications of pHLIP Technology for Cancer Imaging and Therapy.Trends Biotechnol. 2017 Jul;35(7):653-664. doi: 10.1016/j.tibtech.2017.03.014. Epub 2017 Apr 21. Trends Biotechnol. 2017. PMID: 28438340 Free PMC article. Review.
Cited by
-
The role of responsive MRI probes in the past and the future of molecular imaging.Chem Sci. 2024 Nov 27;15(48):20122-20154. doi: 10.1039/d4sc04849k. eCollection 2024 Dec 11. Chem Sci. 2024. PMID: 39611034 Free PMC article. Review.
-
Dendrimer-based Nanoparticle for Dye Sensitized Solar Cells with Improved Efficiency.J Nanomed Nanotechnol. 2018;9(2):496. doi: 10.4172/2157-7439.1000496. Epub 2018 Apr 13. J Nanomed Nanotechnol. 2018. PMID: 29862135 Free PMC article.
-
Recent Advances in Imaging Agents Anchored with pH (Low) Insertion Peptides for Cancer Theranostics.Molecules. 2023 Feb 26;28(5):2175. doi: 10.3390/molecules28052175. Molecules. 2023. PMID: 36903419 Free PMC article. Review.
-
pH-sensitive pHLIP® coated niosomes.Mol Membr Biol. 2016 May-Aug;33(3-5):51-63. doi: 10.1080/09687688.2017.1342969. Epub 2017 Aug 9. Mol Membr Biol. 2016. PMID: 28792261 Free PMC article.
-
Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides.Front Pharmacol. 2024 Mar 13;15:1355893. doi: 10.3389/fphar.2024.1355893. eCollection 2024. Front Pharmacol. 2024. PMID: 38545547 Free PMC article. Review.
References
-
- Srinivas PR, Kramer BS, Srivastava S. Trends in biomarker research for cancer detection. The lancet oncology. 2001;2(11):698–704. - PubMed
-
- Hanke JH, Webster KR, Ronco LV. Protein biomarkers and drug design for cancer treatments. Eur J Cancer Prev. 2004;13(4):297–305. - PubMed
-
- Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006;439(7074):353–357. - PubMed
-
- Shenoy D, Little S, Langer R, Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies. Pharmaceutical research. 2005;22(12):2107–2114. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous